General Information of This Linker
Linker ID
LIN0ZOKVO
Linker Name
CN119630431A-ADC-27-LINKER
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C34H33N5O8S2
Isosmiles
O=C(NCC(NCC(N[C@@H](CC1=CC=CC=C1)C(NCC(O)=O)=O)=O)=O)CCN2C(C(SC3=CC=CC=C3)=C(SC4=CC=CC=C4)C2=O)=O
InChI
InChI=1S/C34H33N5O8S2/c40-26(35-19-27(41)36-20-28(42)38-25(32(45)37-21-29(43)44)18-22-10-4-1-5-11-22)16-17-39-33(46)30(48-23-12-6-2-7-13-23)31(34(39)47)49-24-14-8-3-9-15-24/h1-15,25H,16-21H2,(H,35,40)(H,36,41)(H,37,45)(H,38,42)(H,43,44)/t25-/m0/s1
InChIKey
YZZSLZJZXDXCDS-VWLOTQADSA-N
Pharmaceutical Properties
Molecule Weight
703.799
Polar area
191.08
Complexity
1593.997188
xlogp Value
1.7022
Heavy Count
49
Rot Bonds
17
Hbond acc
9
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
WO2024043319A1 16 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.035 nM
Positive CEACAM6_#84.7 expression (CEACAM6_#84.7 +++/++)
Method Description
In vitro cytotoxicity of ADCs in AsPC-1 cells.
In Vitro Model Pancreatic ductal adenocarcinoma AsPC-1 cells CVCL_0152
References
Ref 1 Antibody-drug complexes